We are live on ! Find out more
CELG

Celgene Corp
CELG

Delisted

CELG was delisted on the 20th of November, 2019.

1,317 hedge funds and large institutions have $33.5B invested in Celgene Corp in 2018 Q4 according to their latest regulatory filings, with 163 funds opening new positions, 382 increasing their positions, 623 reducing their positions, and 195 closing their positions.

New
Increased
Maintained
Reduced
Closed

11% more funds holding in top 10

Funds holding in top 10: 3741 (+4)

10% less call options, than puts

Call options by funds: $1.24B | Put options by funds: $1.37B

3% less funds holding

Funds holding: 1,3641,317 (-47)

16% less first-time investments, than exits

New positions opened: 163 | Existing positions closed: 195

28% less capital invested

Capital invested by funds: $46.6B → $33.5B (-$13.1B)

39% less repeat investments, than reductions

Existing positions increased: 382 | Existing positions reduced: 623

Holders
1,317
Holders Change
-47
Holders Change %
-3.45%
% of All Funds
29.34%
Holding in Top 10
41
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+10.81%
% of All Funds
0.91%
New
163
Increased
382
Reduced
623
Closed
195
Calls
$1.24B
Puts
$1.37B
Net Calls
-$134M
Net Calls Change
+$221M
Name Holding Trade Value Shares
Change
Change in
Stake
NGM
251
North Growth Management
British Columbia, Canada
$11.4M +$4.21M +57,000 +47%
AIM
252
Artemis Investment Management
United Kingdom
$11.4M +$3.44M +46,607 +35%
TAM
253
Trillium Asset Management
Massachusetts
$11.4M -$2.39M -32,352 -15%
PG
254
Pendal Group
Australia
$11.4M +$9.55M +129,417 +269%
IBT
255
International Biotechnology Trust
United Kingdom
$11.4M -$2.07M -28,000 -11%
AAP
256
Aristotle Atlantic Partners
Florida
$11.3M -$164K -2,223 -1%
SCM
257
Stevens Capital Management
Pennsylvania
$11.2M +$2.89M +39,196 +29%
AIM
258
ARK Investment Management
Florida
$11.2M +$1.95M +26,368 +18%
IG
259
ING Group
Netherlands
$11M -$2.35M -31,815 -16%
Commonwealth Equity Services
260
Commonwealth Equity Services
Massachusetts
$11M -$1.15M -15,541 -8%
MYIA
261
Mount Yale Investment Advisors
Colorado
$10.9M -$55.5K -752 -0.6%
TAM
262
Tiverton Asset Management
Delaware
$10.9M -$5.81M -78,775 -32%
BPCE
263
Bank Pictet & Cie (Europe)
Germany
$10.8M -$457K -6,187 -4%
SCM
264
Suffolk Capital Management
New York
$10.8M +$12.5M +168,718 New
ECM
265
Endurant Capital Management
California
$10.8M +$5.18M +70,208 +71%
GIBU
266
Gulf International Bank (UK)
United Kingdom
$10.8M -$5.76M -77,973 -32%
DnB Asset Management
267
DnB Asset Management
Norway
$10.7M +$5.54M +75,002 +81%
NB
268
Norinchukin Bank
Japan
$10.6M +$2.92M +39,497 +31%
FAF
269
Fjarde Ap-fonden
Sweden
$10.5M -$2.13M -28,800 -15%
IA
270
Icon Advisers
Colorado
$10.4M +$18.5K +250 +0.2%
CM
271
CS McKee
Pennsylvania
$10.3M -$133K -1,800 -1%
ACH
272
ArrowMark Colorado Holdings
Colorado
$10.2M +$3.03M +41,000 +35%
M&T Bank
273
M&T Bank
New York
$10.1M -$9.21M -124,716 -44%
PVH
274
Psagot Value Holdings
Israel
$9.96M -$409K -5,545 -3%
GAI
275
General American Investors
New York
$9.93M -$738K -10,000 -6%

CELG Hedge Fund Activity: Q4 2018 in Review

1,317 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in Celgene Corp (CELG) for Q4 2018, worth a combined $33.5B — down 28% from $46.6B a quarter earlier.

Sellers outnumbered buyers: 195 funds closed out of CELG and 163 opened new positions — a net loss of 32 holders — while 623 trimmed existing stakes and 382 added.

The largest buyer was Millennium Management, adding an estimated $379M. The largest seller was Edgewood Management, cutting an estimated $1.16B.

  • 1,317 institutional investors held Celgene Corp (CELG) as of Q4 2018, down from 1,364 in Q3 2018.
  • Funds reported $33.5B of Celgene Corp stock for Q4 2018, down 28% quarter-over-quarter.
  • 163 funds opened new Celgene Corp positions in Q4 2018 and 195 closed out, a net change of -32 holders.
  • The largest Celgene Corp buyer in Q4 2018 was Millennium Management, an estimated $379M added.
  • The largest Celgene Corp seller in Q4 2018 was Edgewood Management, an estimated $1.16B sold.

Based on aggregated 13F filings for Q4 2018.